Jeffrey Lu

Fundador en

Goodman Capital Ltd.

Finance

Health Technology

Technology Services

Perfil

Jeffrey Lu founded Goodman Capital Ltd. in 2013, where he is working as Advisor from 2013 and Engine Biosciences Pte Ltd. in 2016, where he is working as Chief Executive Officer & Director.
Mr. Lu also currently works at Pairx Bio Pte Ltd., as Founding Board Director from 2020 and Nest.Bio Ventures, as Venture Partner from 2017.
Mr. Lu also formerly worked at Think Big Analytics, Inc., as Board Director from 2012 to 2013 and Enleofen Bio Pte Ltd., as Director from 2017 to 2020.
Mr. Lu received his graduate degree from the University of Pennsylvania.

Cargos activos de Jeffrey Lu

Empresas	Cargo	Inicio
Goodman Capital Ltd. Goodman Capital Ltd. Investment ManagersFinance Goodman Capital invests in companies located in Asia and in the USA. The firm targets companies operating in the fields of tech, biotech and real estate sector. It provides financing for seed, early and later stage capital requirements.	Fundador	01/01/2013
Engine Biosciences Pte Ltd. Engine Biosciences Pte Ltd. BiotechnologyHealth Technology Develops novel combinations of genes and drugs for therapeutic and industrial purposes	Fundador	01/01/2016
Nest.Bio Ventures Nest.Bio Ventures Investment ManagersFinance Nest.Bio invests in companies located in the United States. The firm focuses on companies operating in the field of life science sector. It provides financing for early-stage capital requirements.	Inversor de Capital Privado	01/01/2017
Pairx Bio Pte Ltd. Pairx Bio Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Operates a biotechnology company which develops and generates cancer immunotherapies targeting shared tumor-associated antigens derived from aberrantly spliced proteins	Director/Miembro de la Junta	01/01/2020

Todos los cargos activos de Jeffrey Lu

Antiguos cargos conocidos de Jeffrey Lu.

Empresas	Cargo	Fin
Enleofen Bio Pte Ltd. Enleofen Bio Pte Ltd. Pharmaceuticals: MajorHealth Technology Develops antibody therapeutics to treat fibrosis	Director/Miembro de la Junta	01/01/2020
Think Big Analytics, Inc. Think Big Analytics, Inc. Packaged SoftwareTechnology Services Provides big data and advanced analytics consulting services	Director/Miembro de la Junta	02/01/2013

Ver el detalle de la experiencia de Jeffrey Lu.

Formación de Jeffrey Lu.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Jeffrey Lu.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	7
Think Big Analytics, Inc. Think Big Analytics, Inc. Packaged SoftwareTechnology Services Provides big data and advanced analytics consulting services	Technology Services
University of Pennsylvania University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Goodman Capital Ltd. Goodman Capital Ltd. Investment ManagersFinance Goodman Capital invests in companies located in Asia and in the USA. The firm targets companies operating in the fields of tech, biotech and real estate sector. It provides financing for seed, early and later stage capital requirements.	Finance
Engine Biosciences Pte Ltd. Engine Biosciences Pte Ltd. BiotechnologyHealth Technology Develops novel combinations of genes and drugs for therapeutic and industrial purposes	Health Technology
Enleofen Bio Pte Ltd. Enleofen Bio Pte Ltd. Pharmaceuticals: MajorHealth Technology Develops antibody therapeutics to treat fibrosis	Health Technology
Nest.Bio Ventures Nest.Bio Ventures Investment ManagersFinance Nest.Bio invests in companies located in the United States. The firm focuses on companies operating in the field of life science sector. It provides financing for early-stage capital requirements.	Finance
Pairx Bio Pte Ltd. Pairx Bio Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Operates a biotechnology company which develops and generates cancer immunotherapies targeting shared tumor-associated antigens derived from aberrantly spliced proteins	Commercial Services